SS
MRVI icon

SBI Securities’s Maravai LifeSciences MRVI Stock Holding History

SBI Securities’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$880 Hold
311
– – ﹤0.01% 2702
2025
Q4 		$1.01K Sell
311
-103
-25% -$347 ﹤0.01% 2642
2025
Q3 		$1.19K Hold
414
– – ﹤0.01% 2623
2025
Q2 		$998 Buy
414
+90
+28% +$189 ﹤0.01% 2684
2025
Q1 		$716 Sell
324
-85
-21% -$336 ﹤0.01% 2734
2024
Q4 		$2.23K Buy
+409
New +$2.63K ﹤0.01% 2266

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities's MRVI Position: Q1 2026 in Review

SBI Securities held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 311 shares worth $880. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

SBI Securities first reported a position in MRVI in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.23K in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • SBI Securities held 311 shares of Maravai LifeSciences worth $880 as of Q1 2026.
  • SBI Securities left its Maravai LifeSciences share count unchanged in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2702 holding.
  • SBI Securities first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Maravai LifeSciences position peaked at $2.23K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.